Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this exploratory study is to evaluate the effects of sertindole and olanzapine on metabolic parameters and syndrome in patients with schizophrenia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: H. Lundbeck A/S
• Treatments: Olanzapine; Sertindole

Criteria

Inclusion Criteria:

• Patients with schizophrenia

• Participation in 11286 study

• Capable of completing all study-related activities for the duration of the study